Document is current
Any future updates will be listed below
-
Authors
Grosser, Joshua A.
Fehrman, Rachel L.
Keefe, Dennis
Redmon, Martin
Nickells, Robert W. http://orcid.org/0000-0002-2998-5494
-
Funding
Funding for this research was provided by:
Stealth BioTherapeutics Inc
Research to Prevent Blindness (Unrestricted Grant)
National Eye Institute (P30 EY016665)
School of Medicine and Public Health, University of Wisconsin-Madison (Frederick A. Davis Research Chair)
University of Wisconsin-Madison (Vilas Life Cycle Award)
- License Information
-
More Information
Article History
Received: 17 February 2021
Accepted: 13 May 2021
First Online: 22 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: Funding and reagent (elamipretide) for this study was provided by Stealth BioTherapeutics, Inc. Drs. Dennis Keefe and Martin Redmond are employees of Stealth BioTherapeutics, Inc. Drs. Keefe and Redmond participated in the study design and editing of the manuscript.
